High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2011.08.006PMID 21899885PMCID PMC4023812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

  2010cited by this paper
• Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

  2010cited by this paper
• Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes *

  2010cited by this paper
• Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells

  2010cited by this paper
• OGG1 is a novel prognostic indicator in acute myeloid leukaemia

  2010cited by this paper
• How I treat acute myeloid leukemia.

  2010cited by this paper
• High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.

  2010cited by this paper
• FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

  2010cited by this paper
• Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.

  2009cited by this paper
• HOXA9 is required for survival in human MLL-rearranged acute leukemias.

  2009cited by this paper
• Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2.

  2009cited by this paper
• A role for MEIS1 in MLL-fusion gene leukemia.

  2009cited by this paper
• Review Articles (434 articles)

  2008cited by this paper
• Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

  2008cited by this paper
• Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.

  2008influential reference
• Expression of components of the IGF axis in childhood acute myelogenous leukemia

  2008cited by this paper
• Changes of serum growth factors (IGF-I & IGFBP-2) and prediction of response to chemotherapy in patients with acute myeloid leukemia.

  2008cited by this paper
• Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.

  2008cited by this paper
• Changes of serum growth factors (IGF-I & IGFBP-2) and prediction of response to chemotherapy in patients with acute myeloid leukemia.

  2008cited by this paper
• Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.

  2007cited by this paper
• Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway

  2007cited by this paper
• KLF4 suppresses transformation of pre-B cells by ABL oncogenes.

  2007cited by this paper
• High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.

  2006cited by this paper
• Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

  2006cited by this paper
• Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.

  2006cited by this paper
• IDENTIFICATION OF NOVEL GENES WITH PROGNOSTIC VALUE IN CHILDHOOD LEUKEMIA USING cDNA MICROARRAY AND QUANTITATIVE RT-PCR

  2006cited by this paper
• Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML

  2006cited by this paper
• BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.

  2006cited by this paper
• RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

  2005cited by this paper
• Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia.

  2005cited by this paper
• Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.

  2005influential reference
• Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk.

  2005cited by this paper
• Insulin-like growth factors and neoplasia.

  2004cited by this paper
• Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability.

  2004cited by this paper
• Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability

  2004cited by this paper
• Insulin-like growth factors and neoplasia

  2004cited by this paper
• Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia

  2004cited by this paper
• Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia

  2003cited by this paper
• The WT1 Wilms' tumor suppressor gene: a novel target for insulin-like growth factor-I action.

  2003influential reference
• The insulin-like growth factor system and cancer.

  2003cited by this paper
• An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation

  2003cited by this paper
• Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

  2002cited by this paper
• Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

  2001cited by this paper
• Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia

  2001cited by this paper
• Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

  1999cited by this paper
• Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.

  1998cited by this paper
• Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b

  1998cited by this paper
• Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression.

  1998cited by this paper
• The insulin-like growth factor system in regulation of normal and malignant hematopoiesis.

  1995cited by this paper
• Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.

  1992cited by this paper
• Original Articles Design and Methods Prognostic Implications of Mutations and Expression of the Wilms Tumor 1 (wt1) Gene in Adult Acute T-lymphoblastic Leukemia

  year unknowncited by this paper

• Plasma Proteomic Profile of Chemotherapy‐Induced Severe Neutropenia: A Pilot Discovery Phase Study

  2026cites this paper
• Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia

  2025cites this paper
• A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia

  2024cites this paper
• Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

  2023cites this paper
• Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma

  2023cites this paper
• Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line

  2023cites this paper
• METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4

  2022cites this paper
• Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia

  2022cites this paper
• Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting

  2021cites this paper
• CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells

  2021cites this paper
• IGFBP2: integrative hub of developmental and oncogenic signaling network

  2020cites this paper
• [Expression of long non-coding RNA linc00467 in childhood acute myeloid leukemia and its role in drug resistance].

  2020influential citation
• Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.

  2019cites this paper
• Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC

  2019cites this paper
• Le rôle des cellules souches mésenchymateuses médullaires dans la leucémie myélomonocytaire chronique

  2019cites this paper
• Quantitative proteomics of CSF reveals potential predicted biomarkers for extranodal NK‐/T‐cell lymphoma of nasal‐type with ethmoidal sinus metastasis

  2018cites this paper
• Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

  2018cites this paper
• IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma

  2018cites this paper
• Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

  2018cites this paper
• Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor–binding protein 2 in renal cell carcinoma

  2017cites this paper
• Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity

  2017cites this paper
• Insulin-like growth factor (IGF) axis in cancerogenesis.

  2017cites this paper
• Case 1: Term Newborn with Purple Rash at Birth

  2017cites this paper
• High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia

  2016cites this paper
• IGF-binding protein 2 is a candidate target of therapeutic potential in cancer

  2016influential citation
• Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL

  2016cites this paper
• Discovery of cancer linked biomarker genes through common subcluster mining

  2016cites this paper
• High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia

  2016cites this paper
• High Expression of CPT 1 A Predicts Adverse Outcomes : A Potential Therapeutic Target for Acute Myeloid Leukemia

  2016cites this paper
• IGFBP-2 - taking the lead in growth, metabolism and cancer

  2015cites this paper
• IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?

  2015cites this paper
• IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

  2015cites this paper
• FLT3-ITD drives Ara-C resistance in leukemic cells via the induction of RUNX3.

  2015cites this paper
• IGFBP2 POTENTIATES EGFR-STAT3 SIGNALING IN GLIOMA

  2015cites this paper
• Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.

  2015cites this paper
• Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance

  2014cites this paper
• Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma

  2014cites this paper
• Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

  2013cites this paper
• IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

  2013cites this paper
• MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.

  2013cites this paper
• IGFBP 2 / FAK pathway is causally associated with dasatinib resistance in non-small Cell Lung Cancer Cells

  2013cites this paper
• Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization

  2013cites this paper
• FLT3-ITD-associated gene-expression signatures in NPM1-mutated cytogenetically normal acute myeloid leukemia

  2012cites this paper